<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04942600</url>
  </required_header>
  <id_info>
    <org_study_id>HS24851 (B2021:033)</org_study_id>
    <nct_id>NCT04942600</nct_id>
  </id_info>
  <brief_title>Behavioural and Electrophysiological Effects of rTMS in Functional Neurological Disorders</brief_title>
  <official_title>Assessing the Behavioural and Electrophysiological Effects of Repetitive Transcranial Magnetic Stimulation on &quot;Intention&quot; vs &quot;Overt Action&quot; in Patients With Functional Neurological Disorders</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Manitoba</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Winnipeg</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Manitoba</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to better understand Functional Neurological Disorders (FND) by&#xD;
      measuring movement timing and brain activity in patients with FND during deliberate movements&#xD;
      and when expressing an 'intention' to move. This investigation will use non-invasive brain&#xD;
      stimulation to investigate the role of the temporal-occipital-parietal junction in FND.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study seeks to improve our neurophysiological understanding of Functional Neurological&#xD;
      Disorders (FND) by measuring movement timing and brain activity while individuals with FND&#xD;
      perform a simple pointing task.&#xD;
&#xD;
      Behavioural (timing of arm and finger movement) and electrophysiological&#xD;
      (electroencephalography; EEG) measures will be collected both at rest and while participants&#xD;
      perform a voluntary movement task designed to discriminate between brain events related to&#xD;
      intention vs. overt action.&#xD;
&#xD;
      Furthermore, this study will investigate the ability of a non-invasive brain stimulation&#xD;
      technique called repetitive transcranial magnetic stimulation (rTMS) to alter brain activity&#xD;
      in the temporal-occipital-parietal junction (TPJ), a region known to be hypo-active in&#xD;
      individuals with FND. Tasks and cortical recordings will be repeated following rTMS to&#xD;
      determine the effect of brain stimulation on behaviour and brain activity.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">November 1, 2021</start_date>
  <completion_date type="Anticipated">March 31, 2023</completion_date>
  <primary_completion_date type="Anticipated">August 26, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in relative timing of intention-to-act vs action production</measure>
    <time_frame>1 hour: Immediately prior to and following one session of rTMS</time_frame>
    <description>Assessment of change in the lag time between intended and actual action production during pointing and stimulus response tasks.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in resting state activity in temporal-parietal junction brain region</measure>
    <time_frame>1 hour: Immediately prior to and following one session of rTMS</time_frame>
    <description>Assessment of changes in EEG brain activity readings when participants are at rest at various frequencies, primarily targeting delta/theta bands.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in brain activity related to 'intention to act'</measure>
    <time_frame>1 hour: Immediately prior to and following one session of rTMS</time_frame>
    <description>Assessment of changes in ERP waveform amplitude related to the 'intention to act' time-stamp during the movement task.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in brain activity related to motor production</measure>
    <time_frame>1 hour: Immediately prior to and following one session of rTMS</time_frame>
    <description>Assessment of changes in ERP waveform amplitude related to the 'motor production' time-stamp during the movement task.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Functional Neurological Disorder</condition>
  <arm_group>
    <arm_group_label>Repetitive Transcranial Magnetic Stimulation (rTMS)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>1 session (3,000 pulses) of high-frequency (10Hz) repetitive stimulation applied over the right temporal parietal junction (TPJ) gyrus in individuals with Functional Neurological Disorder using a MagStim Rapid2 Transcranial Magnetic Simulation machine.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>MagStim Rapid2 Transcranial Magnetic Simulation</intervention_name>
    <description>A non-invasive method of brain stimulation</description>
    <arm_group_label>Repetitive Transcranial Magnetic Stimulation (rTMS)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Confirmed diagnosis of Functional Neurological Disorder with motor symptoms.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Presence of another comorbid psychiatric disorder;&#xD;
&#xD;
          -  Any contraindication for rTMS (e.g., implanted metal devices; cardiac pacemaker or&#xD;
             pacemaker wires; neurostimulators; implanted pumps, metal in the body [rods, plates,&#xD;
             screws, shrapnel, dentures, IUD] or metallic particles in the body, surgical clips in&#xD;
             the head, previous neurosurgery, cochlear implants, prosthetic heart valves);&#xD;
&#xD;
          -  Currently pregnant.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bruce Bolster, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Winnipeg</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mandana Modirrousta, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Manitoba</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Benjamin Meek</last_name>
    <phone>2042372677</phone>
    <email>rtms@sbgh.mb.ca</email>
  </overall_contact>
  <location>
    <facility>
      <name>St. Boniface Hospital</name>
      <address>
        <city>Winnipeg</city>
        <state>Manitoba</state>
        <zip>R2H2A6</zip>
        <country>Canada</country>
      </address>
    </facility>
    <contact>
      <last_name>Benjamin Meek</last_name>
      <phone>2042372677</phone>
      <email>rtms@sbgh.mb.ca</email>
    </contact>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>June 11, 2021</study_first_submitted>
  <study_first_submitted_qc>June 25, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 28, 2021</study_first_posted>
  <last_update_submitted>October 1, 2021</last_update_submitted>
  <last_update_submitted_qc>October 1, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 4, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nervous System Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

